Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Nanomedicine approaches for corneal diseases.

Chaurasia SS, Lim RR, Lakshminarayanan R, Mohan RR.

J Funct Biomater. 2015 Apr 30;6(2):277-98. doi: 10.3390/jfb6020277. Review.

2.

Prevalence of drug resistance and culture-positive rate among microorganisms isolated from patients with ocular infections over a 4-year period.

Shimizu Y, Toshida H, Honda R, Matsui A, Ohta T, Asada Y, Murakami A.

Clin Ophthalmol. 2013;7:695-702. doi: 10.2147/OPTH.S43323. Epub 2013 Apr 9.

3.

Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal.

Augustin DK, Heimer SR, Tam C, Li WY, Le Due JM, Evans DJ, Fleiszig SM.

Infect Immun. 2011 Feb;79(2):595-605. doi: 10.1128/IAI.00854-10. Epub 2010 Nov 29.

4.

Pathogenesis of contact lens-associated microbial keratitis.

Fleiszig SM, Evans DJ.

Optom Vis Sci. 2010 Apr;87(4):225-32. doi: 10.1097/OPX.0b013e3181d408ee. Review.

5.

The impact of inoculation parameters on the pathogenesis of contact lens-related infectious keratitis.

Tam C, Mun JJ, Evans DJ, Fleiszig SM.

Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3100-6. doi: 10.1167/iovs.09-4593. Epub 2010 Feb 3.

6.

Role of the corneal epithelial basement membrane in ocular defense against Pseudomonas aeruginosa.

Alarcon I, Kwan L, Yu C, Evans DJ, Fleiszig SM.

Infect Immun. 2009 Aug;77(8):3264-71. doi: 10.1128/IAI.00111-09. Epub 2009 Jun 8.

7.

A novel antimicrobial peptidoglycan recognition protein in the cornea.

Ghosh A, Lee S, Dziarski R, Chakravarti S.

Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4185-91. doi: 10.1167/iovs.08-3040. Epub 2009 Apr 22.

Supplemental Content

Support Center